Viewing Study NCT00268892


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-01 @ 4:41 AM
Study NCT ID: NCT00268892
Status: COMPLETED
Last Update Posted: 2010-12-24
First Post: 2005-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
Sponsor: Ferring Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FE200486 CS15A
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Clinical Development Support
Old Organization: Ferring Pharmaceuticals

Collaborators